FDA Logo U.S. Food and Drug AdministrationCenter for Food Safety and Applied Nutrition
U.S. Department of Health and Human Services
horizontal rule

August 2008

horizontal rule

2008 Cardiovascular Biomarkers and Surrogate Endpoints Symposium


September 10-12, 2008
Bethesda North Marriott
Hotel & Conference Center
Bethesda, Maryland

Registration Deadline: September 8, 2008

Program and Registration

Registration, abbreviated agenda, and additional information is available in PDF.
Full agenda is available in PDF.


Peter Libby, M.D.
Chief, Cardiovascular Medicine
Brigham and Women's Hospital

Jean-Claude Tardif, M.D.
Montreal Heart Institute Research Center


  • Examine surrogate endpoints and controversies regarding their use in cardiovascular and diabetes drug approvals
  • Review the latest biomarker and imaging technology data from recently completed clinical trials
  • Identify best practices for biomarker assessment and validation
  • Build a framework for biomarker application in research, development, clinical practice and public health

This meeting is co-sponsored by:

BWH - Brigham and Women's Hospital, A teaching affiliate of Harvard Medical School NHLBI - National Heart Lung and Blood Institute, People Science Health
CMOD - International Partnership for Critical Markers of Disease
U.S. Department of Health and Human Services
U.S. Food and Drug Administration
Center for Food Safety and Applied Nutrition
MHICC - Montreal Heart Institute Coordinating Center
horizontal rule
horizontal rule